▶ 調査レポート

バイオ医薬品受託製造（BCMO）の世界市場（～2026年）
• 英文タイトル：Global Biopharmaceutical Contract Manufacturing Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。バイオ医薬品受託製造（BCMO）の世界市場（～2026年） / Global Biopharmaceutical Contract Manufacturing Market Size, Status and Forecast 2020-2026 / MRC2-11QY11084資料のイメージです。• レポートコード：MRC2-11QY11084
• 出版社/出版日：QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア
• 販売価格（消費税別）
  Single User￥577,200 (USD3,900)▷ お問い合わせ
  Multi User￥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License￥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当調査資料はバイオ医薬品受託製造（BCMO）のグローバル市場について調査・分析したレポートです。種類別（成長因子、インターフェロン、モノクローナル抗体、組換えホルモン、ワクチン、インスリン、その他）市場規模、用途別（自己免疫疾患、腫瘍、代謝性疾患、眼科、心血管疾患、感染症、神経、呼吸器疾患、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別バイオ医薬品受託製造（BCMO）の競争状況、市場シェア
・世界のバイオ医薬品受託製造（BCMO）市場：種類別市場規模 2015年-2020年（成長因子、インターフェロン、モノクローナル抗体、組換えホルモン、ワクチン、インスリン、その他）
・世界のバイオ医薬品受託製造（BCMO）市場：種類別市場規模予測 2021年-2026年（成長因子、インターフェロン、モノクローナル抗体、組換えホルモン、ワクチン、インスリン、その他）
・世界のバイオ医薬品受託製造（BCMO）市場：用途別市場規模 2015年-2020年（自己免疫疾患、腫瘍、代謝性疾患、眼科、心血管疾患、感染症、神経、呼吸器疾患、その他）
・世界のバイオ医薬品受託製造（BCMO）市場：用途別市場規模予測 2021年-2026年（自己免疫疾患、腫瘍、代謝性疾患、眼科、心血管疾患、感染症、神経、呼吸器疾患、その他）
・北米のバイオ医薬品受託製造（BCMO）市場分析：米国、カナダ
・ヨーロッパのバイオ医薬品受託製造（BCMO）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのバイオ医薬品受託製造（BCMO）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のバイオ医薬品受託製造（BCMO）市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのバイオ医薬品受託製造（BCMO）市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Lonza Group、Baxter Biopharma Solutions、Samsung、Fujifilm Diosynth Biotechnologies、Boehringer Ingelheim、Patheon、Rentschler Biotechnologie、Biomeva、Probiogen、Cytovance Biologics、KBI Biopharma、WuXi Biologics、Abzena
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Biopharmaceutical Contract Manufacturing Market
The global Biopharmaceutical Contract Manufacturing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Biopharmaceutical Contract Manufacturing Scope and Market Size
Biopharmaceutical Contract Manufacturing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biopharmaceutical Contract Manufacturing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Lonza Group
Baxter Biopharma Solutions
Samsung
Fujifilm Diosynth Biotechnologies
Boehringer Ingelheim
Patheon
Rentschler Biotechnologie
Biomeva
Probiogen
Cytovance Biologics
KBI Biopharma
WuXi Biologics
Abzena

Market segment by Type, the product can be split into
Growth Factors
Interferons
Monoclonal Antibodies
Recombinant Hormones
Vaccines
Insulin
Others
Market segment by Application, split into
Autoimmune Diseases
Oncology
Metabolic Diseases
Ophthalmology
Cardiovascular Diseases
Infectious Diseases
Neurology
Respiratory Disorders
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biopharmaceutical Contract Manufacturing Revenue
1.4 Market by Type
1.4.1 Global Biopharmaceutical Contract Manufacturing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Growth Factors
1.4.3 Interferons
1.4.4 Monoclonal Antibodies
1.4.5 Recombinant Hormones
1.4.6 Vaccines
1.4.7 Insulin
1.4.8 Others
1.5 Market by Application
1.5.1 Global Biopharmaceutical Contract Manufacturing Market Share by Application: 2020 VS 2026
1.5.2 Autoimmune Diseases
1.5.3 Oncology
1.5.4 Metabolic Diseases
1.5.5 Ophthalmology
1.5.6 Cardiovascular Diseases
1.5.7 Infectious Diseases
1.5.8 Neurology
1.5.9 Respiratory Disorders
1.5.10 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Biopharmaceutical Contract Manufacturing Market Perspective (2015-2026)
2.2 Global Biopharmaceutical Contract Manufacturing Growth Trends by Regions
2.2.1 Biopharmaceutical Contract Manufacturing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Biopharmaceutical Contract Manufacturing Historic Market Share by Regions (2015-2020)
2.2.3 Biopharmaceutical Contract Manufacturing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Biopharmaceutical Contract Manufacturing Market Growth Strategy
2.3.6 Primary Interviews with Key Biopharmaceutical Contract Manufacturing Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceutical Contract Manufacturing Players by Market Size
3.1.1 Global Top Biopharmaceutical Contract Manufacturing Players by Revenue (2015-2020)
3.1.2 Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Players (2015-2020)
3.1.3 Global Biopharmaceutical Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Biopharmaceutical Contract Manufacturing Market Concentration Ratio
3.2.1 Global Biopharmaceutical Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Biopharmaceutical Contract Manufacturing Revenue in 2019
3.3 Biopharmaceutical Contract Manufacturing Key Players Head office and Area Served
3.4 Key Players Biopharmaceutical Contract Manufacturing Product Solution and Service
3.5 Date of Enter into Biopharmaceutical Contract Manufacturing Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Biopharmaceutical Contract Manufacturing Historic Market Size by Type (2015-2020)
4.2 Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020)
5.2 Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Biopharmaceutical Contract Manufacturing Market Size (2015-2020)
6.2 Biopharmaceutical Contract Manufacturing Key Players in North America (2019-2020)
6.3 North America Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020)
6.4 North America Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020)

7 Europe
7.1 Europe Biopharmaceutical Contract Manufacturing Market Size (2015-2020)
7.2 Biopharmaceutical Contract Manufacturing Key Players in Europe (2019-2020)
7.3 Europe Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020)
7.4 Europe Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020)

8 China
8.1 China Biopharmaceutical Contract Manufacturing Market Size (2015-2020)
8.2 Biopharmaceutical Contract Manufacturing Key Players in China (2019-2020)
8.3 China Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020)
8.4 China Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020)

9 Japan
9.1 Japan Biopharmaceutical Contract Manufacturing Market Size (2015-2020)
9.2 Biopharmaceutical Contract Manufacturing Key Players in Japan (2019-2020)
9.3 Japan Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020)
9.4 Japan Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Biopharmaceutical Contract Manufacturing Market Size (2015-2020)
10.2 Biopharmaceutical Contract Manufacturing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020)
10.4 Southeast Asia Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020)

11 India
11.1 India Biopharmaceutical Contract Manufacturing Market Size (2015-2020)
11.2 Biopharmaceutical Contract Manufacturing Key Players in India (2019-2020)
11.3 India Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020)
11.4 India Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Biopharmaceutical Contract Manufacturing Market Size (2015-2020)
12.2 Biopharmaceutical Contract Manufacturing Key Players in Central & South America (2019-2020)
12.3 Central & South America Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020)
12.4 Central & South America Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Lonza Group
13.1.1 Lonza Group Company Details
13.1.2 Lonza Group Business Overview
13.1.3 Lonza Group Biopharmaceutical Contract Manufacturing Introduction
13.1.4 Lonza Group Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020))
13.1.5 Lonza Group Recent Development
13.2 Baxter Biopharma Solutions
13.2.1 Baxter Biopharma Solutions Company Details
13.2.2 Baxter Biopharma Solutions Business Overview
13.2.3 Baxter Biopharma Solutions Biopharmaceutical Contract Manufacturing Introduction
13.2.4 Baxter Biopharma Solutions Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
13.2.5 Baxter Biopharma Solutions Recent Development
13.3 Samsung
13.3.1 Samsung Company Details
13.3.2 Samsung Business Overview
13.3.3 Samsung Biopharmaceutical Contract Manufacturing Introduction
13.3.4 Samsung Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
13.3.5 Samsung Recent Development
13.4 Fujifilm Diosynth Biotechnologies
13.4.1 Fujifilm Diosynth Biotechnologies Company Details
13.4.2 Fujifilm Diosynth Biotechnologies Business Overview
13.4.3 Fujifilm Diosynth Biotechnologies Biopharmaceutical Contract Manufacturing Introduction
13.4.4 Fujifilm Diosynth Biotechnologies Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
13.4.5 Fujifilm Diosynth Biotechnologies Recent Development
13.5 Boehringer Ingelheim
13.5.1 Boehringer Ingelheim Company Details
13.5.2 Boehringer Ingelheim Business Overview
13.5.3 Boehringer Ingelheim Biopharmaceutical Contract Manufacturing Introduction
13.5.4 Boehringer Ingelheim Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
13.5.5 Boehringer Ingelheim Recent Development
13.6 Patheon
13.6.1 Patheon Company Details
13.6.2 Patheon Business Overview
13.6.3 Patheon Biopharmaceutical Contract Manufacturing Introduction
13.6.4 Patheon Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
13.6.5 Patheon Recent Development
13.7 Rentschler Biotechnologie
13.7.1 Rentschler Biotechnologie Company Details
13.7.2 Rentschler Biotechnologie Business Overview
13.7.3 Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing Introduction
13.7.4 Rentschler Biotechnologie Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
13.7.5 Rentschler Biotechnologie Recent Development
13.8 Biomeva
13.8.1 Biomeva Company Details
13.8.2 Biomeva Business Overview
13.8.3 Biomeva Biopharmaceutical Contract Manufacturing Introduction
13.8.4 Biomeva Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
13.8.5 Biomeva Recent Development
13.9 Probiogen
13.9.1 Probiogen Company Details
13.9.2 Probiogen Business Overview
13.9.3 Probiogen Biopharmaceutical Contract Manufacturing Introduction
13.9.4 Probiogen Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
13.9.5 Probiogen Recent Development
13.10 Cytovance Biologics
13.10.1 Cytovance Biologics Company Details
13.10.2 Cytovance Biologics Business Overview
13.10.3 Cytovance Biologics Biopharmaceutical Contract Manufacturing Introduction
13.10.4 Cytovance Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
13.10.5 Cytovance Biologics Recent Development
13.11 KBI Biopharma
10.11.1 KBI Biopharma Company Details
10.11.2 KBI Biopharma Business Overview
10.11.3 KBI Biopharma Biopharmaceutical Contract Manufacturing Introduction
10.11.4 KBI Biopharma Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
10.11.5 KBI Biopharma Recent Development
13.12 WuXi Biologics
10.12.1 WuXi Biologics Company Details
10.12.2 WuXi Biologics Business Overview
10.12.3 WuXi Biologics Biopharmaceutical Contract Manufacturing Introduction
10.12.4 WuXi Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
10.12.5 WuXi Biologics Recent Development
13.13 Abzena
10.13.1 Abzena Company Details
10.13.2 Abzena Business Overview
10.13.3 Abzena Biopharmaceutical Contract Manufacturing Introduction
10.13.4 Abzena Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
10.13.5 Abzena Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Biopharmaceutical Contract Manufacturing Key Market Segments
Table 2. Key Players Covered: Ranking by Biopharmaceutical Contract Manufacturing Revenue
Table 3. Ranking of Global Top Biopharmaceutical Contract Manufacturing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Biopharmaceutical Contract Manufacturing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Growth Factors
Table 6. Key Players of Interferons
Table 7. Key Players of Monoclonal Antibodies
Table 8. Key Players of Recombinant Hormones
Table 9. Key Players of Vaccines
Table 10. Key Players of Insulin
Table 11. Key Players of Others
Table 12. Global Biopharmaceutical Contract Manufacturing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Biopharmaceutical Contract Manufacturing Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Biopharmaceutical Contract Manufacturing Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Biopharmaceutical Contract Manufacturing Market Share by Regions (2015-2020)
Table 16. Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Biopharmaceutical Contract Manufacturing Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Biopharmaceutical Contract Manufacturing Market Growth Strategy
Table 22. Main Points Interviewed from Key Biopharmaceutical Contract Manufacturing Players
Table 23. Global Biopharmaceutical Contract Manufacturing Revenue by Players (2015-2020) (Million US$)
Table 24. Global Biopharmaceutical Contract Manufacturing Market Share by Players (2015-2020)
Table 25. Global Top Biopharmaceutical Contract Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical Contract Manufacturing as of 2019)
Table 26. Global Biopharmaceutical Contract Manufacturing by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Biopharmaceutical Contract Manufacturing Product Solution and Service
Table 29. Date of Enter into Biopharmaceutical Contract Manufacturing Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 32. Global Biopharmaceutical Contract Manufacturing Market Size Share by Type (2015-2020)
Table 33. Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Type (2021-2026)
Table 34. Global Biopharmaceutical Contract Manufacturing Market Size Share by Application (2015-2020)
Table 35. Global Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 36. Global Biopharmaceutical Contract Manufacturing Market Size Share by Application (2021-2026)
Table 37. North America Key Players Biopharmaceutical Contract Manufacturing Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Biopharmaceutical Contract Manufacturing Market Share (2019-2020)
Table 39. North America Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 40. North America Biopharmaceutical Contract Manufacturing Market Share by Type (2015-2020)
Table 41. North America Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 42. North America Biopharmaceutical Contract Manufacturing Market Share by Application (2015-2020)
Table 43. Europe Key Players Biopharmaceutical Contract Manufacturing Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Biopharmaceutical Contract Manufacturing Market Share (2019-2020)
Table 45. Europe Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Biopharmaceutical Contract Manufacturing Market Share by Type (2015-2020)
Table 47. Europe Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Biopharmaceutical Contract Manufacturing Market Share by Application (2015-2020)
Table 49. China Key Players Biopharmaceutical Contract Manufacturing Revenue (2019-2020) (Million US$)
Table 50. China Key Players Biopharmaceutical Contract Manufacturing Market Share (2019-2020)
Table 51. China Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 52. China Biopharmaceutical Contract Manufacturing Market Share by Type (2015-2020)
Table 53. China Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 54. China Biopharmaceutical Contract Manufacturing Market Share by Application (2015-2020)
Table 55. Japan Key Players Biopharmaceutical Contract Manufacturing Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Biopharmaceutical Contract Manufacturing Market Share (2019-2020)
Table 57. Japan Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Biopharmaceutical Contract Manufacturing Market Share by Type (2015-2020)
Table 59. Japan Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Biopharmaceutical Contract Manufacturing Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Biopharmaceutical Contract Manufacturing Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Biopharmaceutical Contract Manufacturing Market Share (2019-2020)
Table 63. Southeast Asia Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Biopharmaceutical Contract Manufacturing Market Share by Type (2015-2020)
Table 65. Southeast Asia Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Biopharmaceutical Contract Manufacturing Market Share by Application (2015-2020)
Table 67. India Key Players Biopharmaceutical Contract Manufacturing Revenue (2019-2020) (Million US$)
Table 68. India Key Players Biopharmaceutical Contract Manufacturing Market Share (2019-2020)
Table 69. India Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 70. India Biopharmaceutical Contract Manufacturing Market Share by Type (2015-2020)
Table 71. India Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 72. India Biopharmaceutical Contract Manufacturing Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Biopharmaceutical Contract Manufacturing Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Biopharmaceutical Contract Manufacturing Market Share (2019-2020)
Table 75. Central & South America Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Biopharmaceutical Contract Manufacturing Market Share by Type (2015-2020)
Table 77. Central & South America Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Biopharmaceutical Contract Manufacturing Market Share by Application (2015-2020)
Table 79. Lonza Group Company Details
Table 80. Lonza Group Business Overview
Table 81. Lonza Group Product
Table 82. Lonza Group Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020) (Million US$)
Table 83. Lonza Group Recent Development
Table 84. Baxter Biopharma Solutions Company Details
Table 85. Baxter Biopharma Solutions Business Overview
Table 86. Baxter Biopharma Solutions Product
Table 87. Baxter Biopharma Solutions Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020) (Million US$)
Table 88. Baxter Biopharma Solutions Recent Development
Table 89. Samsung Company Details
Table 90. Samsung Business Overview
Table 91. Samsung Product
Table 92. Samsung Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020) (Million US$)
Table 93. Samsung Recent Development
Table 94. Fujifilm Diosynth Biotechnologies Company Details
Table 95. Fujifilm Diosynth Biotechnologies Business Overview
Table 96. Fujifilm Diosynth Biotechnologies Product
Table 97. Fujifilm Diosynth Biotechnologies Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020) (Million US$)
Table 98. Fujifilm Diosynth Biotechnologies Recent Development
Table 99. Boehringer Ingelheim Company Details
Table 100. Boehringer Ingelheim Business Overview
Table 101. Boehringer Ingelheim Product
Table 102. Boehringer Ingelheim Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020) (Million US$)
Table 103. Boehringer Ingelheim Recent Development
Table 104. Patheon Company Details
Table 105. Patheon Business Overview
Table 106. Patheon Product
Table 107. Patheon Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020) (Million US$)
Table 108. Patheon Recent Development
Table 109. Rentschler Biotechnologie Company Details
Table 110. Rentschler Biotechnologie Business Overview
Table 111. Rentschler Biotechnologie Product
Table 112. Rentschler Biotechnologie Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020) (Million US$)
Table 113. Rentschler Biotechnologie Recent Development
Table 114. Biomeva Business Overview
Table 115. Biomeva Product
Table 116. Biomeva Company Details
Table 117. Biomeva Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020) (Million US$)
Table 118. Biomeva Recent Development
Table 119. Probiogen Company Details
Table 120. Probiogen Business Overview
Table 121. Probiogen Product
Table 122. Probiogen Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020) (Million US$)
Table 123. Probiogen Recent Development
Table 124. Cytovance Biologics Company Details
Table 125. Cytovance Biologics Business Overview
Table 126. Cytovance Biologics Product
Table 127. Cytovance Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020) (Million US$)
Table 128. Cytovance Biologics Recent Development
Table 129. KBI Biopharma Company Details
Table 130. KBI Biopharma Business Overview
Table 131. KBI Biopharma Product
Table 132. KBI Biopharma Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020) (Million US$)
Table 133. KBI Biopharma Recent Development
Table 134. WuXi Biologics Company Details
Table 135. WuXi Biologics Business Overview
Table 136. WuXi Biologics Product
Table 137. WuXi Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020) (Million US$)
Table 138. WuXi Biologics Recent Development
Table 139. Abzena Company Details
Table 140. Abzena Business Overview
Table 141. Abzena Product
Table 142. Abzena Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020) (Million US$)
Table 143. Abzena Recent Development
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biopharmaceutical Contract Manufacturing Market Share by Type: 2020 VS 2026
Figure 2. Growth Factors Features
Figure 3. Interferons Features
Figure 4. Monoclonal Antibodies Features
Figure 5. Recombinant Hormones Features
Figure 6. Vaccines Features
Figure 7. Insulin Features
Figure 8. Others Features
Figure 9. Global Biopharmaceutical Contract Manufacturing Market Share by Application: 2020 VS 2026
Figure 10. Autoimmune Diseases Case Studies
Figure 11. Oncology Case Studies
Figure 12. Metabolic Diseases Case Studies
Figure 13. Ophthalmology Case Studies
Figure 14. Cardiovascular Diseases Case Studies
Figure 15. Infectious Diseases Case Studies
Figure 16. Neurology Case Studies
Figure 17. Respiratory Disorders Case Studies
Figure 18. Others Case Studies
Figure 19. Biopharmaceutical Contract Manufacturing Report Years Considered
Figure 20. Global Biopharmaceutical Contract Manufacturing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 21. Global Biopharmaceutical Contract Manufacturing Market Share by Regions: 2020 VS 2026
Figure 22. Global Biopharmaceutical Contract Manufacturing Market Share by Regions (2021-2026)
Figure 23. Porter's Five Forces Analysis
Figure 24. Global Biopharmaceutical Contract Manufacturing Market Share by Players in 2019
Figure 25. Global Top Biopharmaceutical Contract Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical Contract Manufacturing as of 2019
Figure 26. The Top 10 and 5 Players Market Share by Biopharmaceutical Contract Manufacturing Revenue in 2019
Figure 27. North America Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Europe Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. China Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Japan Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 31. Southeast Asia Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 32. India Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 33. Central & South America Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2015-2020) (Million US$)
Figure 34. Bottom-up and Top-down Approaches for This Report
Figure 35. Data Triangulation
Figure 36. Key Executives Interviewed

以下、関連資料のご紹介
  • 医薬品研究開発受託機関（CRO）の世界市場（～2026年）
    Global Healthcare Contract Research Organization (CRO) Market Size, Status and Forecast 2020-2026
    MRC2-11QY12119 2020年11月25日 96Pages
    当調査資料は医薬品研究開発受託機関（CRO）のグローバル市場について調査・分析したレポートです。種類別（創薬、前臨床、臨床）市場規模、用途別（プロジェクト管理/臨床供給管理、データ管理、規制/医療、医療執筆、臨床モニタリング、品質管理/保証、バイオ統計、研究者支払い、研究室患者）市場規模、地域別（北...
  • バイオ医薬品発酵システムの世界市場（～2026年）
    Global Biopharmaceutical Fermentation Systems Market Size, Status and Forecast 2020-2026
    MRC2-11QY11085 2020年11月25日 97Pages
    当調査資料はバイオ医薬品発酵システムのグローバル市場について調査・分析したレポートです。種類別（発酵槽、バイオプロセス分析装置、プロセス監視装置、培地・培地調製、培地、バッファー・誘導剤、その他）市場規模、用途別（バイオ製薬会社、委託製造機関、委託研究機関、学術研究所、食品産業、その他）市場規模、地...
  • バイオ医薬品の世界市場（～2026年）
    Global Biopharmaceutical Market Size, Status and Forecast 2020-2026
    MRC2-11QY11086 2020年11月25日 90Pages
    当調査資料はバイオ医薬品のグローバル市場について調査・分析したレポートです。種類別（モノクローナル抗体、インターフェロン、エリスロポエチン、インスリン、その他）市場規模、用途別（腫瘍、糖尿病、心血管、血友病、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリ...
  • 契約バイオマニュファクチャリングサービスの世界市場（～2026年）
    Global Contract Biomanufacturing Services Market Size, Status and Forecast 2020-2026
    MRC2-11QY11497 2020年11月25日 99Pages
    当調査資料は契約バイオマニュファクチャリングサービスのグローバル市場について調査・分析したレポートです。種類別（共同製造、アウトソーシング）市場規模、用途別（臨床検査、医療会社、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国...
  • 医薬品開発・発見用人工知能（AI）の世界市場（～2026年）
    Global Artificial Intelligence For Drug Development and Discovery Market Size, Status and Forecast 2020-2026
    MRC2-11QY10900 2020年11月25日 96Pages
    当調査資料は医薬品開発・発見用人工知能（AI）のグローバル市場について調査・分析したレポートです。種類別（ターゲット識別、分子スクリーニング、デノボドラッグデザイン・ドラッグ最適化、前臨床・臨床試験）市場規模、用途別（製薬・バイオ技術企業、委託研究機関）市場規模、地域別（北米、米国、カナダ、ヨーロッ...
  • バイオ医薬品経口ドラッグデリバリーの世界市場（～2026年）
    Global Biopharmaceutical Oral Drug Delivery Market Insights and Forecast to 2026
    MRC2-11QY03256 2020年11月20日 114Pages
    当調査資料はバイオ医薬品経口ドラッグデリバリーのグローバル市場について調査・分析したレポートです。種類別（通常タンパク質（抗体）、核酸（DNA、RNA、オリゴヌクレオチド））市場規模、用途別（病院薬局、小売薬局、専門薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、...
  • Gタンパク質共役型受容体（GPCR）の世界市場（～2026年）
    Global G-Protein Coupled Receptors (GPCRs) Market Size, Status and Forecast 2020-2026
    MRC2-11QY12070 2020年11月25日 93Pages
    当調査資料はGタンパク質共役型受容体（GPCR）のグローバル市場について調査・分析したレポートです。種類別（製薬、バイオファーマシューティカル）市場規模、用途別（免疫系疾患、腫瘍疾患、その他疾患）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、...
  • 自動抗菌薬感受性検査（AST）の世界市場（～2026年）
    Global Automated Antimicrobial Susceptibility Testing Market Size, Status and Forecast 2020-2026
    MRC2-11QY10934 2020年11月25日 96Pages
    当調査資料は自動抗菌薬感受性検査（AST）のグローバル市場について調査・分析したレポートです。種類別（消耗品、機器）市場規模、用途別（製薬・バイオ技術企業、委託研究機関、病院、病理/診断研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日...
  • フラグメント創薬（FBDD）の世界市場（～2026年）
    Global Fragment-based Drug Discovery Market Size, Status and Forecast 2020-2026
    MRC2-11QY11991 2020年11月25日 95Pages
    当調査資料はフラグメント創薬（FBDD）のグローバル市場について調査・分析したレポートです。種類別（フラグメントスクリーニング、フラグメント最適化）市場規模、用途別（バイオ製薬会社、CRO、学術・研究機関）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア...
  • 人物同定（HI）の世界市場（～2026年）
    Global Human Identification Market Size, Status and Forecast 2020-2026
    MRC2-11QY12249 2020年11月25日 159Pages
    当調査資料は人物同定（HI）のグローバル市場について調査・分析したレポートです。種類別（キャピラリー電気泳動、ポリメラーゼ連鎖反応、次世代シーケンシング、迅速DNA分析、その他）市場規模、用途別（法医学研究所、病院、委託研究機関、研究機関、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ド...
  • バイオ医薬品発酵システムの世界市場（～2026年）バイオ医薬品発酵システムの世界市場（～2026年） Biopharmaceutical fermentation system refers to a biopharmaceutical equipment, it can be divided into fermenters, bioprocess analyzers, process monitoring devices, culture & media preparation. In terms of application, the recombinant proteins segment held a major market share in 2017. High reliance …
  • バイオ医薬品の世界市場（～2026年）バイオ医薬品の世界市場（～2026年） A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood compon…
  • 医薬品研究開発受託機関（CRO）の世界市場（～2026年）医薬品研究開発受託機関（CRO）の世界市場（～2026年） A contract research organization (CRO) is a company that provides support to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis. The key reasons for the rapid growth include increasing investment in R&D programs, preferenc…
  • 契約バイオマニュファクチャリングサービスの世界市場（～2026年）契約バイオマニュファクチャリングサービスの世界市場（～2026年） Market Analysis and Insights: Global Contract Biomanufacturing Services Market The global Contract Biomanufacturing Services market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Contract Biomanufacturing Services Scope and …
  • バイオ医薬品経口ドラッグデリバリーの世界市場（～2026年）バイオ医薬品経口ドラッグデリバリーの世界市場（～2026年） Market Analysis and Insights: Global Biopharmaceutical Oral Drug Delivery Market The global Biopharmaceutical Oral Drug Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Biopharmaceutical Oral Drug Delivery Scop…